OCUL
OCULAR THERAPEUTIX, INC
Key Financials
Operating Income
$-270017000
↓ 57.2%
Revenue
$52.0M
↓ 18.5%
Net Income
$-265939000
↓ 37.4%
EPS (Diluted)
$-1.42
↓ 16.4%
Total Liabilities
$153.7M
↑ 7.8%
Total Assets
$808.1M
↑ 76.5%
Shareholders' Equity
$654.3M
↑ 107.5%
Long-term Debt
$18.0M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 8/3/2026 | View on SEC |
| 10-Q | 8/3/2026 | View on SEC |
| 8-K | 8/3/2026 | View on SEC |
| SCHEDULE 13G/A | 7/29/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OCUL |
| Company Name | OCULAR THERAPEUTIX, INC |
| CIK | 1393434 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-357-4000 |